Takeda (file photo)

Ear­ly da­ta on Takeda's dengue vac­cine is promis­ing, but wait for the full dataset

Take­da’s an­swer to Sanofi’s con­tro­ver­sial dengue vac­cine is here. The Japan­ese drug­mak­er, which is hop­ing to avert the chal­lenges faced by its French ri­val …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.